Package 55150-376-01

Brand: decitabine

Generic: decitabine
NDC Package

Package Facts

Identity

Package NDC 55150-376-01
Digits Only 5515037601
Product NDC 55150-376
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (55150-376-01) / 26 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2021-09-20
Brand decitabine
Generic decitabine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "2c794637-f383-49c6-9f3d-6bcc25e79e66", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0355150376018"], "unii": ["776B62CQ27"], "rxcui": ["636631"], "spl_set_id": ["a99f92cf-88f9-469b-aa69-44831e0bd4ab"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Eugia US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (55150-376-01)  / 26 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "55150-376-01", "marketing_start_date": "20210920"}], "brand_name": "Decitabine", "product_id": "55150-376_2c794637-f383-49c6-9f3d-6bcc25e79e66", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "55150-376", "generic_name": "Decitabine", "labeler_name": "Eugia US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Decitabine", "active_ingredients": [{"name": "DECITABINE", "strength": "50 mg/26mL"}], "application_number": "ANDA214569", "marketing_category": "ANDA", "marketing_start_date": "20210920", "listing_expiration_date": "20261231"}